Drug Shortage Report for NIMOTOP
| Report ID | 75755 |
| Drug Identification Number | 02325926 |
| Brand name | NIMOTOP |
| Common or Proper name | Nimodipine tablets |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NIMODIPINE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100's |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-03-28 |
| Actual start date | |
| Estimated end date | 2019-04-19 |
| Actual end date | 2019-03-25 |
| Shortage status | Avoided shortage |
| Updated date | 2019-03-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-03-26 | French | Compare |
| v5 | 2019-03-26 | English | Compare |
| v4 | 2019-02-22 | French | Compare |
| v3 | 2019-02-22 | English | Compare |
| v2 | 2019-02-14 | French | Compare |
| v1 | 2019-02-14 | English | Compare |
Showing 1 to 6 of 6